- Investing Ideas
- Mexican Software Transformative Artificial intelligence (AI) Healthcare Stocks
Mexican Software Transformative Artificial intelligence (AI) Healthcare Stocks
Results
130
Artificial intelligence (AI) is set to transform healthcare by enhancing diagnostics, personalizing medicine, boosting operational efficiency, expanding remote care, and accelerating research. AI outperforms humans in detecting diseases like cancer from scans, tailors treatments using genetic and lifestyle data, and streamlines hospital workflows with tools like predictive analytics and automated transcription. It powers telemedicine, monitors chronic conditions in real-time, and speeds up drug discovery by analyzing vast datasets for insights into complex diseases. Despite challenges like data privacy, bias, and integration costs, AI’s ability to improve accuracy, access, and affordability could save billions and extend lives, marking a seismic shift in healthcare delivery and outcomes.
130 companies
SS Innovations International
Market Cap: US$758.5m
Operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally.
SSII
US$3.79
7D
0.3%
1Y
-24.0%
HeartSciences
Market Cap: US$8.7m
A medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness.
HSCS
US$2.74
7D
-1.8%
1Y
-34.1%
GC Genome
Market Cap: ₩112.8b
Operates as a clinical genome analysis company in South Korea.
A340450
₩4,770.00
7D
-0.6%
1Y
-48.3%
Odysight.ai
Market Cap: US$74.8m
Develops, produces, and markets visual monitoring artificial intelligence (AI) solutions in Israel, the United States, and internationally.
ODYS
US$4.46
7D
11.2%
1Y
-7.1%
OmniAb
Market Cap: US$332.0m
A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.
OABI
US$2.29
7D
-5.4%
1Y
12.8%
Sanofi
Market Cap: €91.5b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SAN
€76.23
7D
0.6%
1Y
-8.2%
Mettler-Toledo International
Market Cap: US$26.2b
Manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally.
MTD
US$1,296.17
7D
-0.9%
1Y
5.9%
Ortoma
Market Cap: SEK 446.8m
A medical technology company, focuses on Al-based technology for orthopedic surgical procedures in Sweden.
ORT B
SEK 9.55
7D
1.1%
1Y
-27.9%
Aiforia Technologies Oyj
Market Cap: €67.9m
Together with its subsidiary, Aiforia Inc., provides AI-based image analysis software used in clinical, preclinical, and academic laboratories to pathologists and researchers in Finland, rest of Europe, North America, and internationally.
AIFORIA
€1.82
7D
-1.9%
1Y
-46.6%
Perimeter Medical Imaging AI
Market Cap: CA$50.6m
A medical technology company, provides advanced imaging solutions to address unmet medical needs.
PINK
CA$0.33
7D
20.0%
1Y
24.5%
Lepu Medical Technology (Beijing)
Market Cap: CN¥22.7b
Engages in the research, development, and manufacturing of cardiac interventional medical devices in China and internationally.
300003
CN¥12.30
7D
-2.1%
1Y
-17.4%
Q & M Dental Group (Singapore)
Market Cap: S$525.6m
An investment holding company, provides private dental healthcare services in Singapore, Malaysia, and China.
QC7
S$0.56
7D
0.9%
1Y
30.6%
Lantheus Holdings
Market Cap: US$6.9b
Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.
LNTH
US$105.64
7D
-3.9%
1Y
29.9%
SciBase Holding
Market Cap: SEK 333.3m
A medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally.
SCIB
SEK 32.60
7D
-3.6%
1Y
-11.9%
Evaxion
Market Cap: US$26.4m
A clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.
EVAX
US$3.17
7D
-7.0%
1Y
19.2%
Personalis
Market Cap: US$1.5b
Develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.
PSNL
US$14.07
7D
3.3%
1Y
120.9%
Stryker
Market Cap: US$126.4b
Operates as a medical technology company in the United States and internationally.
SYK
US$329.78
7D
1.0%
1Y
-15.3%
MindWalk Holdings
Market Cap: US$71.0m
Operates as a bio-native AI company.
HYFT
US$1.43
7D
-8.9%
1Y
-3.4%
Tempus AI
Market Cap: US$10.5b
Operates as a healthcare technology company in the United States.
TEM
US$58.23
7D
-3.4%
1Y
2.4%
IXICO
Market Cap: UK£20.2m
Provides data analytics services to biopharmaceutical industry in the United States, the United Kingdom, the Netherlands, Denmark, Switzerland, Ireland, Europe, and internationally.
IXI
UK£0.092
7D
12.1%
1Y
-5.1%
HealthStream
Market Cap: US$820.4m
Provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States.
HSTM
US$28.08
7D
-1.2%
1Y
5.6%
Zimmer Biomet Holdings
Market Cap: US$17.7b
Operates as a medical technology company worldwide.
ZBH
US$91.34
7D
4.4%
1Y
-2.6%
Gubra
Market Cap: DKK 5.8b
A disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally.
GUBRA
DKK 355.60
7D
8.4%
1Y
-14.3%
Simulations Plus
Market Cap: US$368.9m
Develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide.
SLP
US$18.24
7D
-0.8%
1Y
7.5%
Evolent Health
Market Cap: US$661.4m
Through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.
EVH
US$5.88
7D
3.0%
1Y
-47.4%
EMV Capital
Market Cap: UK£14.8m
A venture capital firm specializing in seed, growth capital, early and mid stage investments.
EMVC
UK£0.53
7D
2.9%
1Y
10.4%
Fresenius SE KGaA
Market Cap: €24.0b
A health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa.
FRE
€42.57
7D
0.3%
1Y
1.5%
Basilea Pharmaceutica
Market Cap: CHF 678.1m
A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.
BSLN
CHF 54.70
7D
0.7%
1Y
13.5%
Siemens Healthineers
Market Cap: €38.6b
Through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China.
SHL
€34.59
7D
-1.1%
1Y
-24.9%
Labcorp Holdings
Market Cap: US$22.7b
Provides laboratory services.
LH
US$276.81
7D
-3.5%
1Y
10.9%
Photocure
Market Cap: NOK 1.6b
Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.
PHO
NOK 59.00
7D
0.3%
1Y
5.2%
Medtronic
Market Cap: US$107.4b
Develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally.
MDT
US$83.87
7D
0.8%
1Y
-6.7%
HBM Holdings
Market Cap: HK$10.1b
A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.
2142
HK$11.65
7D
2.4%
1Y
50.5%
Singular Health Group
Market Cap: AU$66.5m
A medical technology company, engages in the development and provision of 3DiCom software medical technology in Australia.
SHG
AU$0.21
7D
0%
1Y
-40.8%
Beijing Airdoc Technology
Market Cap: HK$1.1b
Provides AI-empowered retina-based early detection, diagnosis, and health risk assessment solutions in Mainland China and internationally.
2251
HK$10.54
7D
-3.8%
1Y
-18.4%
Eastwood Bio-Medical Canada
Market Cap: CA$65.4m
Eastwood Bio-Medical Canada Inc. markets, develops research, and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia.
EBM
CA$0.95
7D
-3.1%
1Y
95.9%